Thermo Fisher Scientific Completes Acquisition of Brammer Bio

赛默飞世尔17亿美金收购Brammer Bio

2019-05-02 08:10:00 PR Newswire


 Thermo Fisher Scientific Inc. , the world leader in serving science, announced today that it has completed its previously announced acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for approximately $1.7 billion in cash.  The completion of the transaction follows the receipt of all required regulatory approvals. Brammer Bio has nearly 600 employees at primary locations in Massachusetts and Florida and will become part of Thermo Fisher's Pharma Services business within its Laboratory Products and Services Segment. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit Media Contact Information: Ron O'Brien Phone: 781-622-1242 E-mail: Investor Contact Information: Ken Apicerno Phone: 781-622-1294 E-mail: multimedia:
世界领先的服务科学公司 Thermo Fisher Scientific Inc .今天宣布,已经完成了先前宣布的以约17亿美元现金收购基因和细胞疗法病毒载体制造领域的领导者 Brammer Bio 的交易。交易完成后,收到所有必需的监管批准。 Brammer Bio 在马萨诸塞州和弗洛里达州的主要地点拥有近600名员工,将成为 Thermo Fisher 制药服务业务在其实验室产品和服务分部的一部分。 关于 Thermo Fisher 科学 Thermo Fisher Scientific Inc .是全球领先的科学服务公司,全球收入超过240亿美元,员工约7万人。我们的使命是使我们的客户使世界更健康、更清洁、更安全。我们帮助客户加速生命科学研究,解决复杂的分析挑战,改善患者诊断,向市场提供药物,提高实验室生产力。通过我们的主要品牌—— Thermo Scientific 、 Applied Biosystems 、 Invitrogen 、 Fisher Scientific 和 Unity Lab Services ——我们提供无与伦比的创新技术、购买便利性和全面服务的组合。详情请访问 。 媒体联系信息: RonO'Brien 电话:781-622-1242电子邮件: ron 。obrien @ 投资者联系方式: Ken Apicerno 电话:781-622-1294电子邮件: ken 。apicerno @ 多媒体:。html